MG
Clinical trials for MG explained in plain language.
Never miss a new study
Get alerted when new MG trials appear
Sign up with your email to follow new studies for MG, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists test One-Shot cell therapy to reset the immune system in autoimmune patients
Disease control Recruiting nowThis early-stage study is testing a new type of cell therapy called RD06-05 for people with active autoimmune diseases. The therapy involves modifying a patient's own immune cells (CAR-T cells) to target and remove harmful immune cells, aiming to reset the immune system. The main…
Matched conditions: MG
Phase: EARLY_PHASE1 • Sponsor: Nanjing Bioheng Biotech Co., Ltd. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New drug combo aims to boost muscle disease treatment
Disease control Recruiting nowThis study is testing whether adding a new drug called empasiprubart to an existing treatment (efgartigimod) can better control symptoms of myasthenia gravis. It will involve about 70 adults with a specific type of this muscle-weakening disease who have had only a partial improve…
Matched conditions: MG
Phase: PHASE2 • Sponsor: argenx • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New hope for Muscle-Weakening disease: multiple drug trials launch
Disease control Recruiting nowThis study aims to test the safety and effectiveness of several different drug combinations for people with myasthenia gravis, a condition that causes muscle weakness. It will enroll about 70 adults who have been diagnosed with the disease and are on stable treatment. The goal is…
Matched conditions: MG
Sponsor: argenx • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC